tiprankstipranks
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market
Want to see AVXL full AI Analyst Report?

Anavex Life Sciences (AVXL) Blogger Opinions & Sentiment

1,747 Followers

Blogger Sentiment

Bullish: 70.00%
Sector Average
Bullish
AVXL Blogger sentiment is based on 2 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% GuruFocus
50% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Anavex (AVXL) Reports Strong Cash Position with Long-Term Financial Outlook
GuruFocus
Does Anavex's Alzheimer's Drug Actually Confer Benefit?
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of AVXL?
Seeking Alpha’s The Political Economist has a Bullish Sentiment.
    What do Motley Fool contributors think of AVXL?
    Currently there's no blogger sentiment for AVXL.
    What Is AVXL’s Blogger Sentiment?
    AVXL’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for AVXL?
      The most recent blogger prediction for AVXL was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited
          PRNAFAlterity Therapeutics